U.S. stock futures were higher this morning, with the Dow futures gaining more than 300 points on Thursday.
Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA) fell sharply in today's pre-market trading after the company reported data from KOASTAL-1 study of Navacaprant in major depressive disorder.
Neumora Therapeutics shares dipped 82.8% to $1.82 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
Now Read This:
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
